【本文由浙江裕丰律师事务所厉健律师供稿，不代表新浪财经的立场。厉健律师，系中国法学会证券法 学研究会理事、中国证券业协会证券纠纷调解员，2009年荣获"浙江省优秀青年律师"称号。2003年至 今，厉健律师代理投资者告赢五粮液、大智慧等130余家上市公司并获赔，成效显著。其中，祥源文 化、赵薇案入选2019年度人民法院十大商事案例，杭萧钢构案入选2012年度"全国法院十大调解案例"， 辉丰股份案系江苏省首例证券纠纷普通代表人案。厉健律师接受中央电视台、新华社、证券时报、证券 日报、中国证券报、人民法院报、第一财经等100余家新闻媒体采访一千余篇（次）。执业证号： 13301200210145176）】 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 近日，投资者诉浙江方正电机（维权）股份有限公司（代码：002196 简称：方正电机）证券虚假陈述 案持续推进。 原告代理人之一、曾代理投资者告赢130余家上市公司并获赔的浙江裕丰律师事务所厉健律师表示 ...

受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 2025年12月16日晚，山东朗进科技（维权）股份有限公司（简称：朗进科技，证券代码：300594）发布 《关于公司及相关当事人收到<行政处罚事先告知书>的公告》。 曾代理投资者告赢130余家上市公司并获赔的浙江裕丰律师事务所厉健律师表示，根据处罚预告，朗进 科技涉嫌证券虚假陈述，受损投资者可依法索赔。（厉健律师专栏） 经查明，朗进科技涉嫌违法的事实如下：2024 年2月至2025年7月，朗进科技及其子公司成都朗进交通 装备有限公司、青岛朗进新能源设备有限公司、武汉朗进科技有限公司、长春朗进交通装备有限公司、 青岛朗进数字能源技术有限公司、济南朗进新能源科技有限公司直接或通过第三方公司与控股股东青岛 朗进集团有限公司（以下简称朗进集团）及其子公司莱芜朗进电气有限公司、济南瑞青科技有限公司发 生关联方非经营性资金占用，累计发生额为41，520.63万元。其中，2024年2月至6月关联方非经营性资 金 ...

Core Viewpoint - Jiangsu Nuotai Aosaino Biopharmaceutical Co., Ltd. (ST Nuotai, stock code: 688076) has been penalized by the China Securities Regulatory Commission (CSRC) for significant violations, including false financial reporting and misleading public disclosures [1][5]. Group 1: Financial Misconduct - The 2021 annual report of Nuotai Biopharmaceutical contained false records, with a reported revenue of 30 million yuan from a technology transfer to Zhejiang Huabei Pharmaceutical, which lacked the financial capability to pay for the transaction [1][5]. - The technology transfer was deemed to lack commercial substance, leading to an inflated revenue of 30 million yuan and an inflated total profit of 25.9516 million yuan, representing 20.64% of the reported profit for that period [1][5][6]. Group 2: Regulatory Actions - The CSRC has ordered Nuotai Biopharmaceutical to rectify its practices, issued a warning, and imposed a fine of 47.4 million yuan. Additionally, six responsible individuals were fined a total of 28.8 million yuan [2][6]. Group 3: Investor Rights and Legal Recourse - Investors who suffered losses due to the company's false statements can file lawsuits for compensation, covering losses from price differences, commissions, and stamp duty [3][7]. - The eligibility for claims is set for investors who purchased Nuotai Biopharmaceutical shares between April 28, 2022, and October 23, 2024, and still held the shares by the latter date [3][7].

此前，鹏博士多次因信披违规被监管处罚： 此前，易事特已于2024年12月31日收到中国证监会下发的《行政处罚决定书》（[2024]147 号）。 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 2025年12月16日，北京盈科（杭州）律师事务所陈宇霞律师再次向法院递交了一批股民针对易事特 （300376）的证券虚假陈述责任纠纷案的起诉材料。目前该案的诉讼时效仅剩不足五个月，符合条件的 股民如需参与索赔，应在诉讼时效届满前采取相关措施。 中国证监会经调查认定，易事特涉嫌通过不具有商业实质的虚假贸易业务、融资性代采业务、代理业务 和数据中心集成业务虚增营业收入、营业成本、利润总额，导致易事特披露的2017年至2021年年度报告 存在虚假记载。其中，2017年虚增营业收入822，061，666.54 元，占当年披露营业收入的11.23%，虚 增营业成本 729，065，621.31 元，占当年披露营业成本的12.33%，虚增利润总额427，936.5 ...

Core Viewpoint - The ongoing legal case against Zhejiang Furun Digital Technology Co., Ltd. (*ST Furun) involves allegations of false statements in securities, with investors encouraged to file claims before the deadline approaches [1][5]. Group 1: Legal Proceedings - On May 18, 2024, *ST Furun announced it received an administrative penalty decision from the Zhejiang Securities Regulatory Bureau, confirming the company inflated revenue and costs through fictitious business activities, leading to false disclosures in its 2020, 2021, and 2022 financial reports [2][6]. - The total inflated revenue from 2020 to mid-2022 amounted to approximately 717.23 million yuan, with inflated costs totaling about 715.51 million yuan [2][6]. - Specific annual figures include: 2020 inflated revenue of 365.77 million yuan (12.04% of reported revenue) and inflated costs of 364.92 million yuan (13.30% of reported costs); 2021 inflated revenue of 142.61 million yuan (10.87%) and inflated costs of 143.23 million yuan (11.11%); and for the first half of 2022, inflated revenue of 208.85 million yuan (69.05%) and inflated costs of 207.35 million yuan (69.79%) [2][6]. Group 2: Investor Claims - Investors who purchased *ST Furun shares between April 27, 2021, and April 27, 2023, and held them until the latter date are eligible to file claims for compensation, despite the company's delisting [3][7]. - Required documentation for claims includes securities account information, stock reconciliation statements from April 1, 2021, to December 2023, and contact information [4][7]. - The scope of compensation includes losses from the difference in investment, commissions, and stamp duty losses as per the new judicial interpretation regarding securities false statements [2][6].

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 一、信披违规收被处罚 上海沪紫律师事务所刘鹏律师代理的投资者诉联泰环保（维权）证券虚假陈述案近日已提交一批次案件 至法院立案审理。回溯本案，此前该公司因资金占用导致2022年年报、半年报存在问题，联泰环保被证 监会处罚。 随后投资者维权正式开启。该处罚主要源于联泰环保在信息披露方面存在虚假陈述行为，具体涉及资金 占用事项的隐瞒，严重侵害了广大投资者的合法权益。 2024年9月6日，联泰环保公告称公司于9月5日收到了广东证监局下发的《行政处罚决定书》，公司存在 资金占用问题。 广东证监局依据相关法律法规，对联泰环保及其相关责任人作出了严厉的处罚决定，以维护市场的公 平、公正和透明。 二、两类投资者可索赔 经查明，公司未按规定及时披露关联方2022年至2023年1月非经营性资金占用；2022年半年度报告、 2022年年度报告存在重大遗漏；主要为未披露资 ...

2025年12月10日，广东惠伦晶体（维权）科技股份有限公司发布《关于公司及相关当事人收到 <行政处 罚事先告知书> 的公告》，因惠伦晶体涉信披违规，证监会拟决定对其作出行政处罚。 陈宇霞律师提醒，凡在2021年4月23日至2025年4月24日之间买入惠伦晶体股票，且在2025年4月25日之 后继续持有或卖出亏损的投资人（具体索赔条件以法院认定的为准）。（惠伦晶体维权入口） 违法事实： 证监会经调查认定惠伦晶体存在以下违法事实： 2020年，惠伦晶体以采购设备及材料、预付工程款等名义向东莞市某科技有限公司等7家公司支出款 项，并最终划转至控股股东新疆惠伦股权投资合伙企业（有限合伙）（以下简称新疆惠伦）及公司实际 控制人赵积清本人等关联方银行账户，用于归还新疆惠伦股权质押款及赵积清个人借款。 上述关联方 非经营性资金往来构成关联方对公司的资金占用，2020年累计发生额为28，330，000元，期末余额为 26，630，000元，资金占用发生额占惠伦晶体 2020 年年度报告披露净资产的 5.12%。 一、惠伦晶体未按规定披露资金占用事项，2020年年度报告存在重大遗漏 索赔相关 按照相关法律法规的规定，上市公司 ...

Core Viewpoint - The ongoing lawsuit against Weichuang Group Co., Ltd. (formerly known as *ST Weichuang) involves allegations of false statements in securities disclosures, with investors seeking compensation for losses incurred due to these violations [1][2]. Summary by Sections Legal Proceedings - Investors have filed a lawsuit against Weichuang Group, with the legal representation provided by Zhejiang Yufeng Law Firm, which has a history of winning cases for investors against over 130 listed companies [1][4]. - Recent submissions of legal materials to the Guangzhou Intermediate People's Court have been made by the law firm on behalf of affected investors [4]. Regulatory Findings - The Guangdong Securities Regulatory Bureau issued an administrative penalty decision on June 23, 2025, identifying several violations by Weichuang Group, including failure to disclose the 2023 annual report and the 2024 semi-annual report within the legal timeframe [2][4]. - Additional findings from the regulatory body include false records in the 2023 semi-annual report and the 2023 third-quarter report, as well as failure to disclose significant changes in the actual control of the company [2][4]. Investor Compensation - According to judicial interpretations regarding false statements, investors whose rights have been harmed can file lawsuits for compensation, which may include losses from price differences, commissions, and stamp duty [5]. - Investors who purchased *ST Weichuang shares between June 21, 2023, and December 22, 2023, and held them until the market close on December 22, 2023, are eligible to seek compensation, subject to court verification [5].

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 根据最高人民法院虚假陈述司法解释，上市公司等因证券虚假陈述行为导致投资者权益受损，投资者可 以依法起诉索赔，索赔范围包括投资差额损失、佣金和印花税损失。 "我们正在分批代理投资者起诉。"厉健律师表示，根据司法解释，暂定：在2021年4月23日至2025年4月 24日期间买入惠伦晶体股票，并在2025年4月24日收盘仍持有该股票的受损股民可索赔。索赔条件以法 院认定为准。（惠伦晶体维权入口） 索赔需提供证券开户信息查询单、股票对账单（2021年4月1日起至今）、联系方式等。 【本文由浙江裕丰律师事务所厉健律师供稿，不代表新浪财经的立场。厉健律师，系中国法学会证券法 学研究会理事、中国证券业协会证券纠纷调解员，2009年荣获"浙江省优秀青年律师"称号。2003年至 今，厉健律师代理投资者告赢五粮液、大智慧等130余家上市公司并获赔，成效显著。其中，祥源 ...

Core Viewpoint - The case against Hainan Huatie involves allegations of false statements in securities, leading to a lawsuit filed by investors seeking compensation for losses incurred during a specific period [1][4]. Group 1: Legal Proceedings - The Zhao Jingguo lawyer team has submitted a lawsuit on behalf of investors against Zhejiang Haikong Nanke Huatie Technology Co., Ltd. for securities fraud [1][2]. - The lawsuit allows investors who purchased shares between March 5, 2025, and September 30, 2025, and still hold them, to voluntarily register for compensation [1][5]. - As of October 17, 2025, Hainan Huatie received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into information disclosure violations [1][4]. Group 2: Investor Compensation Conditions - Investors eligible for compensation must have bought shares during the specified period and held them, regardless of whether they sold after October 1, 2025 [3][5]. - The specific compensation range will be determined by the court [5].